Evaluation of safety and efficacy of combine therapy of immunoglobulin and colchicine in Kawasaki disease.
Not Applicable
- Conditions
- Kawasaki disease
- Registration Number
- JPRN-UMIN000024764
- Lead Sponsor
- St. Marianna University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
We exclude patients who fulfill below conditions 1) Patients who had history of hyper reaction for colchicine. 2) Patients who participated in other clinical trial in these 12 weeks. 3) Patients who have history of obvious allergy for any drug and food. 4) renal insufficiency.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety
- Secondary Outcome Measures
Name Time Method